{"id":49625,"date":"2026-02-20T18:13:57","date_gmt":"2026-02-20T18:13:57","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/immunocytokines-market-mordor\/"},"modified":"2026-09-25T02:49:52","modified_gmt":"2026-09-24T17:49:52","slug":"immunocytokines-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/immunocytokines-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \uc774\ubba4\ub178\uc0ac\uc774\ud1a0\uce74\uc778 \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2025 &#8211; 2030\ub144)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/immunocytokines-market-1753791806760-major-players.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/immunocytokines-market-size-image-1753868314744.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 IL-2 \uae30\ubc18 \uc735\ud569 \uce58\ub8cc\uc81c\uc758 \uc784\uc0c1\uc801 \uc131\uacf5\uc774 \ud22c\uc790 \uc790\uae08 \uc720\uce58<\/li>\n<li class=\"toc-level-3\">4.2.2 \uba74\uc5ed\uc0ac\uc774\ud1a0\uce74\uc778 + \uba74\uc5ed\uad00\ubb38\uc5b5\uc81c\uc81c \uc694\ubc95\uc758 \ucc44\ud0dd \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.3 \uc81c\uc870 \ud50c\ub7ab\ud3fc \ubc1c\uc804\uc73c\ub85c COGS \ubc0f \ubc30\uce58 \uc2e4\ud328 \uac10\uc18c<\/li>\n<li class=\"toc-level-3\">4.2.4 \uc790\uac00\uba74\uc5ed \uc9c8\ud658 \uc801\uc751\uc99d\uc73c\ub85c \ud30c\uc774\ud504\ub77c\uc778 \ud655\uc7a5 (\uc608: F8-IL10)<\/li>\n<li class=\"toc-level-3\">4.2.5 \ud76c\uadc0 \uc885\uc591\uc5d0 \ub300\ud55c \ud76c\uadc0\uc758\uc57d\ud488 \uc778\uc13c\ud2f0\ube0c<\/li>\n<li class=\"toc-level-3\">4.2.6 \uc628\ub514\ub9e8\ub4dc, \uc800\ubd84\uc790 \uc804\ud658 \uac00\ub2a5 \uba74\uc5ed\uc0ac\uc774\ud1a0\uce74\uc778<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \uc0ac\uc774\ud1a0\uce74\uc778 \ubc29\ucd9c \uc99d\ud6c4\uad70 \ubc0f \uad00\ub828 \uc548\uc804 \ubb38\uc81c<\/li>\n<li class=\"toc-level-3\">4.3.2 \ub192\uc740 GMP \uc2a4\ucf00\uc77c\uc5c5 \ubc0f QA\/QC \ube44\uc6a9<\/li>\n<li class=\"toc-level-3\">4.3.3 \ubd88\ucda9\ubd84\ud55c \ubc14\uc774\uc624\ub9c8\ucee4 \uae30\ubc18 \ud658\uc790 \uacc4\uce35\ud654<\/li>\n<li class=\"toc-level-3\">4.3.4 \uc774\uc911\ud2b9\uc774\uc131 \ubc0f \uc138\ud3ec \uce58\ub8cc \uc591\uc2dd\uc758 \uacbd\uc7c1\uc801 \uc555\ub825<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \uac00\uce58 \/ \uacf5\uae09\ub9dd \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">4.5 \uaddc\uc81c \ud658\uacbd<\/li>\n<li class=\"toc-level-2\">4.6 \uae30\uc220 \uc804\ub9dd<\/li>\n<li class=\"toc-level-2\">4.7 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.7.1 \uacf5\uae09\uc5c5\uccb4\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.7.2 \uad6c\ub9e4\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.7.3 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.4 \ub300\uccb4\uc7ac\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21 (\uac00\uce58-USD)<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \uc0ac\uc774\ud1a0\uce74\uc778 \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 IL-2 \uae30\ubc18 \uba74\uc5ed\uc0ac\uc774\ud1a0\uce74\uc778<\/li>\n<li class=\"toc-level-3\">5.1.2 IL-12 \uae30\ubc18 \uba74\uc5ed\uc0ac\uc774\ud1a0\uce74\uc778<\/li>\n<li class=\"toc-level-3\">5.1.3 IL-15 \uae30\ubc18 \uba74\uc5ed\uc0ac\uc774\ud1a0\uce74\uc778<\/li>\n<li class=\"toc-level-3\">5.1.4 IFN-\u03b1 \uae30\ubc18 \uba74\uc5ed\uc0ac\uc774\ud1a0\uce74\uc778<\/li>\n<li class=\"toc-level-3\">5.1.5 TNF-\u03b1 \uae30\ubc18 \uba74\uc5ed\uc0ac\uc774\ud1a0\uce74\uc778<\/li>\n<li class=\"toc-level-3\">5.1.6 \uae30\ud0c0 (IL-21, GM-CSF, \ubcf5\ud569)<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \uce58\ub8cc \uc601\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \uc885\uc591\ud559<\/li>\n<li class=\"toc-level-3\">5.2.2 \uc790\uac00\uba74\uc5ed &amp; \uc5fc\uc99d\uc131 \uc9c8\ud658<\/li>\n<li class=\"toc-level-3\">5.2.3 \uac10\uc5fc\uc131 \uc9c8\ud658<\/li>\n<li class=\"toc-level-3\">5.2.4 \uae30\ud0c0 (\uc12c\uc720\uc99d, \uc548\uacfc\ud559)<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \uc804\ub2ec \ubc29\uc2dd\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \uc804\uc2e0 \uc815\ub9e5 \uc8fc\uc0ac<\/li>\n<li class=\"toc-level-3\">5.3.2 \uc885\uc591 \ub0b4 \uc8fc\uc0ac<\/li>\n<li class=\"toc-level-3\">5.3.3 \uc720\uc804\uc790 \/ \ubca1\ud130 \uc778\ucf54\ub529 (\uc608: mRNA, \ubc14\uc774\ub7ec\uc2a4)<\/li>\n<li class=\"toc-level-3\">5.3.4 \uc6a9\ud574\uc131 \ubc14\uc774\ub7ec\uc2a4 \uc804\ub2ec<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.4.1 \uc81c\uc57d &amp; \uc0dd\uba85\uacf5\ud559 \uae30\uc5c5<\/li>\n<li class=\"toc-level-3\">5.4.2 \ud559\uc220 &amp; \uc5f0\uad6c \uae30\uad00<\/li>\n<li class=\"toc-level-3\">5.4.3 \uc704\ud0c1 \uc0dd\uc0b0 \uae30\uad00<\/li>\n<li class=\"toc-level-3\">5.4.4 \ubcd1\uc6d0 \/ \uc804\ubb38 \ud074\ub9ac\ub2c9<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.5 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.5.1 \ubd81\ubbf8<\/li>\n<li class=\"toc-level-4\">5.5.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.5.1.3 \uba55\uc2dc\ucf54<\/li>\n<li class=\"toc-level-3\">5.5.2 \uc720\ub7fd<\/li>\n<li class=\"toc-level-4\">5.5.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.5.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.5.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.5.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.5.2.6 \uae30\ud0c0 \uc720\ub7fd<\/li>\n<li class=\"toc-level-3\">5.5.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-4\">5.5.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.5.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.5.3.4 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.5.3.5 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.3.6 \uae30\ud0c0 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-3\">5.5.4 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.5.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.5.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.5.4.3 \uae30\ud0c0 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-3\">5.5.5 \ub0a8\ubbf8<\/li>\n<li class=\"toc-level-4\">5.5.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.5.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.5.5.3 \uae30\ud0c0 \ub0a8\ubbf8<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/li>\n<li class=\"toc-level-2\">6.2 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">6.3 \uae30\uc5c5 \ud504\ub85c\ud544 (\uae00\ub85c\ubc8c \uac1c\uc694, \uc2dc\uc7a5 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34 \uc815\ubcf4(\uc0ac\uc6a9 \uac00\ub2a5\ud55c \uacbd\uc6b0), \uc804\ub7b5 \uc815\ubcf4, \uc8fc\uc694 \uae30\uc5c5\uc758 \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 \ubc0f \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ud3ec\ud568)\n<ul>\n<li class=\"toc-level-3\">6.3.1 Philogen S.p.A.<\/li>\n<li class=\"toc-level-3\">6.3.2 Nektar Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.3 ImmunityBio Inc.<\/li>\n<li class=\"toc-level-3\">6.3.4 F. Hoffmann-La Roche AG<\/li>\n<li class=\"toc-level-3\">6.3.5 Novartis AG<\/li>\n<li class=\"toc-level-3\">6.3.6 Bristol Myers Squibb Co.<\/li>\n<li class=\"toc-level-3\">6.3.7 Sanofi S.A.<\/li>\n<li class=\"toc-level-3\">6.3.8 Xilio Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.9 Sorrento Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.10 Alkermes plc<\/li>\n<li class=\"toc-level-3\">6.3.11 Regeneron Pharmaceuticals<\/li>\n<li class=\"toc-level-3\">6.3.12 AbbVie Inc.<\/li>\n<li class=\"toc-level-3\">6.3.13 Amgen Inc.<\/li>\n<li class=\"toc-level-3\">6.3.14 AstraZeneca plc<\/li>\n<li class=\"toc-level-3\">6.3.15 Merck &amp; Co.<\/li>\n<li class=\"toc-level-3\">6.3.16 Affimed N.V.<\/li>\n<li class=\"toc-level-3\">6.3.17 SynOx Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.18 Oncotelic Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.19 Sutro Biopharma<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c &amp; \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\uba74\uc5ed\uc0ac\uc774\ud1a0\uce74\uc778 \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5, \ub3d9\ud5a5 \ubc0f \uc608\uce21 (2025-2030)<\/p>\n<p>\uc2dc\uc7a5 \uac1c\uc694<\/p>\n<p>\uba74\uc5ed\uc0ac\uc774\ud1a0\uce74\uc778(Immunocytokines) \uc2dc\uc7a5\uc740 2025\ub144 10\uc5b5 3\ucc9c\ub9cc \ub2ec\ub7ec \uaddc\ubaa8\uc5d0\uc11c 2030\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 12.24%\uc758 \uacac\uace0\ud55c \uc131\uc7a5\ub960(CAGR)\uc744 \uae30\ub85d\ud558\uba70 18\uc5b5 4\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0 \uc774\ub97c \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc131\uc7a5\uc740 IL-2 \ubc0f IL-15 \uae30\ubc18 \uc735\ud569 \uce58\ub8cc\uc81c\uc758 \uac15\ub825\ud55c \uc784\uc0c1\uc801 \uc99d\uac70, FDA \ud601\uc2e0 \uce58\ub8cc\uc81c(Breakthrough) \ubc0f \ud76c\uadc0\uc758\uc57d\ud488(Orphan) \uc9c0\uc815\uacfc \uac19\uc740 \uc9c0\uc18d\uc801\uc778 \uaddc\uc81c \uc778\uc13c\ud2f0\ube0c, \ub300\ud615 \uc81c\uc57d \ud30c\ud2b8\ub108\ub85c\ubd80\ud130\uc758 \uc790\ubcf8 \uc720\uc785\uc5d0 \ud798\uc785\uc740 \ubc14\uac00 \ud07d\ub2c8\ub2e4. \ub610\ud55c, AI \uae30\ubc18 \uc81c\uc5b4\uc640 \uc5f0\uc18d \uc0dd\ubb3c\uacf5\uc815\uc744 \uacb0\ud569\ud55c \uc81c\uc870 \ud50c\ub7ab\ud3fc \uc5c5\uadf8\ub808\uc774\ub4dc\ub294 \uc81c\uc870\uc6d0\uac00(COGS)\ub97c \ucd5c\ub300 30%\uae4c\uc9c0 \uc808\uac10\ud558\uc5ec \uc18c\uaddc\ubaa8 \uc2e0\uaddc \uae30\uc5c5\uc758 \ube60\ub978 \uc131\uc7a5\uc744 \ucd09\uc9c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uba74\uc5ed\uad00\ubb38\uc5b5\uc81c\uc81c\uc640 \uba74\uc5ed\uc0ac\uc774\ud1a0\uce74\uc778\uc744 \uacb0\ud569\ud55c \uc2dc\ub108\uc9c0 \uc694\ubc95\uc740 \ub09c\uce58\uc131 \uc885\uc591 \ud658\uc790\uc758 \uc0dd\uc874\uc728\uc744 \uac1c\uc120\ud558\uace0 \uc801\uaca9 \ud658\uc790\uad70\uc744 \ud655\ub300\ud558\uace0 \uc788\uc73c\uba70, \ucc28\uc138\ub300 \uc720\uc804\uc790 \ubc0f \ubca1\ud130 \uc778\ucf54\ub529 \ubc29\uc2dd\uc740 \uc9c0\uc18d\uc801\uc778 \uc0dd\uccb4 \ub0b4 \uc0ac\uc774\ud1a0\uce74\uc778 \ubc1c\ud604\uc744 \uac00\ub2a5\ud558\uac8c \ud560 \uac83\uc73c\ub85c \uae30\ub300\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc9c0\uc5ed\uc801\uc73c\ub85c\ub294 \ubd81\ubbf8\uac00 \uc2ec\uce35\uc801\uc778 \uc784\uc0c1 \uc2dc\ud5d8 \uc778\ud504\ub77c\uc640 \uad00\ub300\ud55c \ud76c\uadc0\uc758\uc57d\ud488 \uc138\uae08 \uacf5\uc81c\ub97c \ud1b5\ud574 \uc120\uc810 \uc6b0\uc704\ub97c \uc720\uc9c0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 \ud638\uc8fc, \uc77c\ubcf8, \uc911\uad6d \ub4f1\uc5d0\uc11c \uaddc\uc81c \uc2b9\uc778\uc774 \uac00\uc18d\ud654\ub418\uba74\uc11c \uac00\uc7a5 \ube60\ub978 \uc99d\ubd84 \uc131\uc7a5\uc744 \ubcf4\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud559\uc220 \uc2a4\ud540\uc624\ud504 \uae30\uc5c5\ub4e4\uc774 \uae30\ucd08 \uc5f0\uad6c \uc131\uacfc\ub97c \uc784\uc0c1 \ud504\ub85c\uadf8\ub7a8\uc73c\ub85c \uc804\ud658\ud558\uba74\uc11c \ud601\uc2e0 \uc18d\ub3c4\uc640 \ud2c8\uc0c8 \uc801\uc751\uc99d\uc5d0 \uc9d1\uc911\ud558\uba70 \uacbd\uc7c1 \uac15\ub3c4\uac00 \uc2ec\ud654\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \ud1b5\uacc4 (2025-2030)<\/p>\n<p>*   \uc5f0\uad6c \uae30\uac04: 2019 &#8211; 2030\ub144<br \/>\n*   2025\ub144 \uc2dc\uc7a5 \uaddc\ubaa8: 10\uc5b5 3\ucc9c\ub9cc \ub2ec\ub7ec<br \/>\n*   2030\ub144 \uc2dc\uc7a5 \uaddc\ubaa8: 18\uc5b5 4\ucc9c\ub9cc \ub2ec\ub7ec<br \/>\n*   \uc131\uc7a5\ub960 (2025-2030): 12.24% CAGR<br \/>\n*   \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc2dc\uc7a5: \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<br \/>\n*   \uac00\uc7a5 \ud070 \uc2dc\uc7a5: \ubd81\ubbf8<br \/>\n*   \uc2dc\uc7a5 \uc9d1\uc911\ub3c4: \uc911\uac04<br \/>\n*   \uc8fc\uc694 \uae30\uc5c5: \ud544\ub85c\uc820(Philogen S.p.A.), \ub125\ud0c0 \ud14c\ub77c\ud4e8\ud2f1\uc2a4(Nektar Therapeutics), \uc774\ubba4\ub2c8\ud2f0\ubc14\uc774\uc624(ImmunityBio Inc.), F. \ud638\ud504\ub9cc-\ub77c \ub85c\uc288(F. Hoffmann-La Roche AG), \uc2e4\ub9ac\uc624 \ud14c\ub77c\ud4e8\ud2f1\uc2a4(Xilio Therapeutics)<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \ub3d9\uc778 \ubc0f \uc81c\uc57d \uc694\uc778<\/p>\n<p>\uc2dc\uc7a5 \ub3d9\uc778:<\/p>\n<p>1.  IL-2 \uc735\ud569 \uce58\ub8cc\uc81c\uc758 \uc784\uc0c1\uc801 \uc131\uacf5: BCG-\ubd88\uc751\uc131 \ubc29\uad11\uc554 \uce58\ub8cc\uc81c \uc548\ud06c\ud2f0\ubc14(ANKTIVA)\uc758 5\ub144\uac04 \uc9c0\uc18d\uc801\uc778 \ubc18\uc751 \ub370\uc774\ud130\ub294 IL-2 \uc124\uacc4 \uc6d0\ub9ac\ub97c \uc785\uc99d\ud588\uc73c\uba70, \ube44\uc18c\uc138\ud3ec\ud3d0\uc554\uc5d0\uc11c\uc758 PD-1 \uc5b5\uc81c\uc81c\uc640\uc758 \ubcd1\uc6a9 \uc694\ubc95\uc5d0\uc11c\ub3c4 \uc720\ub9dd\ud55c \uacb0\uacfc\ub97c \ubcf4\uc5ec\uc8fc\uace0 \uc788\uc2b5\ub2c8\ub2e4. NK \ubc0f CD8 T \uc138\ud3ec\uc758 \uc120\ud0dd\uc801 \uc99d\uc2dd\uacfc \uc870\uc808 T \uc138\ud3ec(Treg) \ud655\uc7a5 \uc5b5\uc81c\ub294 \uc591\ud638\ud55c \uc548\uc804\uc131 \ud504\ub85c\ud30c\uc77c\uc744 \uc81c\uacf5\ud558\uba70, FDA\uc758 \ucdcc\uc7a5\uc554 RMAT \uc9c0\uc815\uc740 \uac1c\ubc1c \uc77c\uc815\uc744 \ub2e8\ucd95\ud558\uace0 \uc790\ubcf8 \uc704\ud5d8\uc744 \ub0ae\ucd94\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n2.  \uba74\uc5ed\uc0ac\uc774\ud1a0\uce74\uc778 + \uba74\uc5ed\uad00\ubb38\uc5b5\uc81c\uc81c \ubcd1\uc6a9 \uc694\ubc95 \ucc44\ud0dd \uc99d\uac00: \uc774 \ubcd1\uc6a9 \uc694\ubc95\uc740 \uc9c0\uce5c \ub9bc\ud504\uad6c\ub97c \uc7ac\ud65c\uc131\ud654\ud558\uace0 \ud56d\uc6d0 \ub178\ucd9c\uc744 \ud655\ub300\ud558\uc5ec \uc885\uc591 \ud68c\ud53c\ub97c \ud574\uacb0\ud569\ub2c8\ub2e4. QUILT 3.055 \uc5f0\uad6c\uc5d0\uc11c 2\ucc28 \ud3d0\uc554 \ud658\uc790\uc758 \uc0dd\uc874\uc728 \uac1c\uc120\uc774 \ubcf4\uace0\ub418\uc5c8\uc73c\uba70, PD-L1 \uc0c1\ud0dc\uc640 \ubb34\uad00\ud558\uac8c \uc9c0\uc18d\uc801\uc778 \ud65c\uc131\uc744 \ubcf4\uc5ec \uac1c\ubc1c\uc0ac\ub4e4\uc774 \ub2e8\uc77c \uc694\ubc95\uc5d0\uc11c \ubcd1\uc6a9 \uc694\ubc95 \uc911\uc2ec\uc73c\ub85c \ud30c\uc774\ud504\ub77c\uc778 \uc6b0\uc120\uc21c\uc704\ub97c \uc804\ud658\ud558\ub3c4\ub85d \uc7a5\ub824\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n3.  \uc81c\uc870 \ud50c\ub7ab\ud3fc \ubc1c\uc804\uc73c\ub85c \uc778\ud55c COGS \uac10\uc18c: \uc790\ub3d9 \uad00\ub958 \uc0dd\ubb3c\ubc18\uc751\uae30(perfusion bioreactors)\uc640 \uc778\ub77c\uc778 \ubd84\uc11d(inline analytics)\uc740 \ubc30\uce58 \uc2e4\ud328\uc728\uc744 40% \uc904\uc774\uace0 \uc81c\uc870\uc6d0\uac00\ub97c \uc57d 30% \uc808\uac10\ud588\uc2b5\ub2c8\ub2e4. AI \uae30\ubc18 \uc608\uce21 \uc81c\uc5b4\ub294 \ubcf5\uc7a1\ud55c \ub2e4\uc911 \ub3c4\uba54\uc778 \uc735\ud569 \ub2e8\ubc31\uc9c8\uc758 \uc218\uc728 \uc7ac\ud604\uc131\uc744 \ucd5c\uc801\ud654\ud558\uba70, \uc77c\ud68c\uc6a9 \uc870\ub9bd\uccb4(single-use assemblies)\ub294 \ube60\ub978 \uc0dd\uc0b0 \ub77c\uc778 \uc804\ud658\uc744 \uac00\ub2a5\ud558\uac8c \ud569\ub2c8\ub2e4.<br \/>\n4.  \uc790\uac00\uba74\uc5ed \uc9c8\ud658\uc73c\ub85c\uc758 \ud30c\uc774\ud504\ub77c\uc778 \ud655\uc7a5: \uc0ac\ub178\ud53c(Sanofi)\uc640 \uc2e0\ud14c\uce74\uc778(Synthekine)\uc758 IL-10 \uba74\uc5ed\uc0ac\uc774\ud1a0\uce74\uc778 \uac1c\ubc1c \ud611\ub825\uc740 \uc815\ubc00 \uc0ac\uc774\ud1a0\uce74\uc778 \uc870\uc808\uc774 \uad11\ubc94\uc704\ud55c \uba74\uc5ed\uc5b5\uc81c\uc81c\ub97c \ub300\uccb4\ud560 \uc218 \uc788\ub2e4\ub294 \ub300\ud615 \uc81c\uc57d\uc0ac\uc758 \ud655\uc2e0\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4. \uc885\uc591\ud559 \uc548\uc804\uc131 \ub370\uc774\ud130\uc758 \uc7ac\ud65c\uc6a9\uc740 \uc790\uac00\uba74\uc5ed \uc9c8\ud658 \uc784\uc0c1 \uc77c\uc815\uc744 \ub2e8\ucd95\ud558\uba70, \ub09c\uce58\uc131 \uc790\uac00\uba74\uc5ed \uc9c8\ud658\uc758 \uc720\ubcd1\ub960 \uc99d\uac00\ub294 \uba74\uc5ed\uc0ac\uc774\ud1a0\uce74\uc778 \uc2dc\uc7a5\uc758 \uc0c8\ub85c\uc6b4 \uc131\uc7a5 \ub3d9\ub825\uc774 \ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n5.  \ud76c\uadc0 \uc885\uc591\uc5d0 \ub300\ud55c \ud76c\uadc0\uc758\uc57d\ud488 \uc778\uc13c\ud2f0\ube0c: \ubbf8\uad6d \ubc0f EU \uc9c0\uc5ed\uc5d0\uc11c \ud76c\uadc0 \uc885\uc591\uc5d0 \ub300\ud55c \ud76c\uadc0\uc758\uc57d\ud488 \uc778\uc13c\ud2f0\ube0c\ub294 \uc790\ubcf8 \uc704\ud5d8\uc744 \uc904\uc774\uace0 \uac1c\ubc1c\uc744 \ucd09\uc9c4\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc81c\uc57d \uc694\uc778:<\/p>\n<p>1.  \uc0ac\uc774\ud1a0\uce74\uc778 \ubc29\ucd9c \uc99d\ud6c4\uad70 \ubc0f \uad00\ub828 \uc548\uc804\uc131 \ubb38\uc81c: \uba74\uc5ed \ud65c\uc131\ud654 \uc99d\uac00\ub294 3\ub4f1\uae09 \uc774\uc0c1\uc758 \ubd80\uc791\uc6a9 \uc704\ud5d8\uc744 \uc218\ubc18\ud558\uba70, \uba74\ubc00\ud55c \ubaa8\ub2c8\ud130\ub9c1\uc774 \ud544\uc694\ud569\ub2c8\ub2e4. \uc548\ud06c\ud2f0\ubc14(ANKTIVA)\uc758 \uc6a9\ub7c9 \uc99d\ub7c9 \ucf54\ud638\ud2b8\uc5d0\uc11c \uc694\ub85c \uc790\uadf9 \ubc0f \uc77c\uc2dc\uc801\uc778 \ud06c\ub808\uc544\ud2f0\ub2cc \uc0c1\uc2b9\uc774 \uad00\ucc30\ub418\uc5c8\uc73c\uba70, \uace0\uc6a9\ub7c9\uc5d0\uc11c\ub294 \ub3c5\uc131 \ud55c\uacc4\uc5d0 \uadfc\uc811\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n2.  \ub192\uc740 GMP \uc2a4\ucf00\uc77c\uc5c5 \ubc0f QA\/QC \ube44\uc6a9: \ub2e4\uc911 \ub3c4\uba54\uc778 \uc735\ud569 \uc0ac\uc774\ud1a0\uce74\uc778\uc758 \uc0c1\uc5c5\uc801 \uc81c\uc870\uc5d0\ub294 \uc804\uc6a9 \uc2dc\uc124, \ubc14\uc774\ub7ec\uc2a4 \uc81c\uac70 \uac80\uc99d \ubc0f \uace0\uae09 \ubd84\uc11d\uc774 \ud544\uc694\ud558\uba70, \ucd1d \uc2dc\uc124 \ud22c\uc790 \ube44\uc6a9\uc774 5\ucc9c\ub9cc \ub2ec\ub7ec\ub97c \ucd08\uacfc\ud560 \uc218 \uc788\uc5b4 \uc18c\uaddc\ubaa8 \uac1c\ubc1c\uc0ac\uc5d0\uac8c\ub294 \ubd80\ub2f4\uc774 \ub429\ub2c8\ub2e4.<br \/>\n3.  \ubd88\ucda9\ubd84\ud55c \ubc14\uc774\uc624\ub9c8\ucee4 \uae30\ubc18 \ud658\uc790 \uacc4\uce35\ud654: \ud6a8\uacfc\uc801\uc778 \uce58\ub8cc\ub97c \uc704\ud55c \ud658\uc790 \uc120\ubcc4\uc5d0 \ud544\uc694\ud55c \ubc14\uc774\uc624\ub9c8\ucee4\uc758 \ubd80\uc871\uc740 \uc7a5\uae30\uc801\uc778 \uacfc\uc81c\ub85c \ub0a8\uc544\uc788\uc2b5\ub2c8\ub2e4.<br \/>\n4.  \uc774\uc911\ud2b9\uc774\uc131 \ud56d\uccb4 \ubc0f \uc138\ud3ec \uce58\ub8cc \uc591\uc2dd\uc758 \uacbd\uc7c1 \uc555\ub825: \uc774\uc911\ud2b9\uc774\uc131 \ud56d\uccb4 \ubc0f \uc138\ud3ec \uce58\ub8cc\uc81c\uc640 \uac19\uc740 \ub300\uccb4 \uce58\ub8cc\ubc95\uc758 \ubc1c\uc804\uc740 \uba74\uc5ed\uc0ac\uc774\ud1a0\uce74\uc778 \uc2dc\uc7a5\uc5d0 \uacbd\uc7c1 \uc555\ub825\uc744 \uac00\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc138\uadf8\uba3c\ud2b8 \ubd84\uc11d<\/p>\n<p>\uc0ac\uc774\ud1a0\uce74\uc778 \uc720\ud615\ubcc4:<br \/>\nIL-2 \uc735\ud569 \uad6c\uc870\uccb4\ub294 2024\ub144 \uba74\uc5ed\uc0ac\uc774\ud1a0\uce74\uc778 \uc2dc\uc7a5 \uc810\uc720\uc728\uc758 39.24%\ub97c \ucc28\uc9c0\ud558\uba70 \uc0c1\uc5c5\uc801 \uc120\ub450\ub97c \uc720\uc9c0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uadf8\ub7ec\ub098 IL-12 \uad6c\uc870\uccb4\ub294 2030\ub144\uae4c\uc9c0 16.32%\uc758 CAGR\ub85c \uac00\uc7a5 \uc5ed\ub3d9\uc801\uc778 \uc131\uc7a5\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. XTX301\uacfc \uac19\uc740 \uc885\uc591 \ud65c\uc131\ud654 \ud615\ud0dc\uc758 IL-12\ub294 \uc885\uc591 \ubbf8\uc138\ud658\uacbd \ub0b4\uc5d0\uc11c \ud6a8\uc18c\uc801\uc73c\ub85c \ud65c\uc131\ud654\ub420 \ub54c\uae4c\uc9c0 \ube44\ud65c\uc131 \uc0c1\ud0dc\ub97c \uc720\uc9c0\ud558\uc5ec \uac74\uac15\ud55c \uc870\uc9c1\uc744 \ubcf4\ud638\ud558\uba74\uc11c \uac15\ub825\ud55c \uc120\ucc9c\uc131 \ubc0f \uc801\uc751\uc131 \uba74\uc5ed\uc744 \uc720\ub3c4\ud569\ub2c8\ub2e4. IL-15 \uc735\ud569 \uc124\uacc4\ub294 NK \uae30\uc5b5 \uc138\ud3ec\ub97c \ubaa8\uc9d1\ud558\uc5ec \uc9c0\uc18d\uc131\uc744 \uc5f0\uc7a5\ud558\uba70, IFN-\u03b1 \ud504\ub85c\uadf8\ub7a8\uc740 \ud608\uc561\uc554\uc5d0\uc11c \uc911\uae30 \uc5f0\uad6c\ub97c \uc9c4\ud589 \uc911\uc785\ub2c8\ub2e4. TNF-\u03b1 \ud6c4\ubcf4 \ubb3c\uc9c8\uc740 \uacfc\uac70\uc758 \uc804\uc2e0 \ub3c5\uc131 \ubb38\uc81c\ub85c \uc778\ud574 \uc2e0\uc911\ud558\uac8c \uc9c4\ud589\ub418\uace0 \uc788\uc73c\ub098, \uc0c8\ub85c\uc6b4 \ub9c8\uc2a4\ud0b9 \uae30\uc220\uc774 \uad00\uc2ec\uc744 \ub2e4\uc2dc \ubd88\ub7ec\uc77c\uc73c\ud0a4\uace0 \uc788\uc2b5\ub2c8\ub2e4. IL-21 \ubc0f GM-CSF \ud558\uc774\ube0c\ub9ac\ub4dc\ub97c \ud3ec\ud568\ud558\ub294 &#8220;\uae30\ud0c0&#8221; \ucf54\ud638\ud2b8\ub294 \uba74\uc5ed \uc870\uc808\uc744 \ubbf8\uc138 \uc870\uc815\ud558\ub294 \uc870\ud569 \ud398\uc774\ub85c\ub4dc(payload) \ucd94\uc138\ub97c \ubcf4\uc5ec\uc90d\ub2c8\ub2e4.<\/p>\n<p>\uce58\ub8cc \uc601\uc5ed\ubcc4:<br \/>\n\uc885\uc591\ud559\uc740 2024\ub144 \uba74\uc5ed\uc0ac\uc774\ud1a0\uce74\uc778 \uc2dc\uc7a5 \uaddc\ubaa8\uc758 48.24%\ub97c \ucc28\uc9c0\ud558\uba70, \ubc29\uad11\uc554, \ud3d0\uc554, \ud751\uc0c9\uc885 \uc2b9\uc778\uc744 \ud1b5\ud574 \ud56d\uc554 \ud6a8\ub2a5\uc744 \uc785\uc99d\ud588\uc2b5\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \uc790\uac00\uba74\uc5ed \ubc0f \uc5fc\uc99d\uc131 \uc9c8\ud658\uc740 IL-10 \ubc0f IL-2 \ubcc0\uc774\uccb4\uac00 \uad11\ubc94\uc704\ud55c \uba74\uc5ed \uc5b5\uc81c \uc5c6\uc774 \ud56d\uc6d0 \ud2b9\uc774\uc801 \ub0b4\uc131\uc744 \ubaa9\ud45c\ub85c \ud568\uc5d0 \ub530\ub77c 2030\ub144\uae4c\uc9c0 14.57%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc785\ub2c8\ub2e4. \ucd08\uae30 \uc804\uc2e0\uc131 \ud64d\ubc18\uc131 \ub8e8\ud478\uc2a4(systemic lupus erythematosus) \uc784\uc0c1 \uc2dc\ud5d8\uc5d0\uc11c\ub294 \uc774\uc911 \uac00\ub2e5 DNA \uc5ed\uac00 \ubc0f \uc2a4\ud14c\ub85c\uc774\ub4dc \uc694\uad6c\ub7c9 \uac10\uc18c\uac00 \ubcf4\uace0\ub418\uc5b4 \uc9c8\ubcd1 \uc870\uc808 \ub2a5\ub825\uc744 \uc2dc\uc0ac\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc804\ub2ec \ubc29\uc2dd\ubcc4:<br \/>\n\uc804\uc2e0 \uc815\ub9e5 \uc8fc\uc0ac(Systemic IV)\ub294 \uc784\uc0c1\uc758\uc758 \uc775\uc219\ud568, \uc608\uce21 \uac00\ub2a5\ud55c \uc57d\ub3d9\ud559, \uae30\uc874 \uc8fc\uc785 \uc13c\ud130\uc640\uc758 \uc778\ud504\ub77c \ud638\ud658\uc131\uc73c\ub85c \uc778\ud574 61.55%\uc758 \uc810\uc720\uc728\ub85c \uc5ec\uc804\ud788 \uc9c0\ubc30\uc801\uc785\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \uc720\uc804\uc790 \ubc0f \ubca1\ud130 \uc778\ucf54\ub529 \ud50c\ub7ab\ud3fc\uc740 mRNA \ubc0f \ubc14\uc774\ub7ec\uc2a4 \uc2dc\uc2a4\ud15c\uc774 \uc9c0\uc18d\uc801\uc778 \uc0dd\uccb4 \ub0b4 \uc0ac\uc774\ud1a0\uce74\uc778 \ubc1c\ud604\uc744 \uc81c\uacf5\ud558\uc5ec \ud22c\uc5ec \ube48\ub3c4\uc640 \ubcd1\uc6d0 \uccb4\ub958 \uc2dc\uac04\uc744 \uc904\uc784\uc5d0 \ub530\ub77c 16.89%\uc758 CAGR\ub85c \uc131\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc885\uc591 \ub0b4 \uc8fc\uc0ac(Intratumoral injection)\ub294 \uc811\uadfc \uac00\ub2a5\ud55c \ubcd1\ubcc0\uc774 \uc788\ub294 \uace0\ud615\uc554\uc5d0\uc11c \uad6d\uc18c \uba74\uc5ed\uc6d0\uc131 \uc138\ud3ec \uc0ac\uba78 \ubc0f \ud56d\uc6d0 \ud655\uc0b0\uc744 \uc785\uc99d\ud558\uba70 \ubaa8\uba58\ud140\uc744 \uc5bb\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4:<br \/>\n\uc81c\uc57d \ubc0f \uc0dd\uba85\uacf5\ud559 \uae30\uc5c5\uc740 \uc790\ubcf8 \uc790\uc6d0, \uaddc\uc81c \uc804\ubb38\uc131 \ubc0f \ud655\ub9bd\ub41c \ud310\ub9e4 \ub124\ud2b8\uc6cc\ud06c\ub97c \ud65c\uc6a9\ud558\uc5ec \uc81c\ud488 \ucd9c\uc2dc\ub97c \uac00\uc18d\ud654\ud558\uba70 2024\ub144 \uba74\uc5ed\uc0ac\uc774\ud1a0\uce74\uc778 \uc2dc\uc7a5 \uc810\uc720\uc728\uc758 53.41%\ub97c \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \ud559\uc220 \ubc0f \uc5f0\uad6c \uae30\uad00\uc740 \uae30\ucd08 \uc5f0\uad6c\uc5d0\uc11c \uc784\uc0c1 \uc801\uc6a9\uc73c\ub85c \ud601\uc2e0\uc801\uc778 \uc0ac\uc774\ud1a0\uce74\uc778 \uc5d4\uc9c0\ub2c8\uc5b4\ub9c1 \uac1c\ub150\uc744 \uc804\ud658\ud558\uace0 \uc774\ub97c \uc0b0\uc5c5 \ud30c\ud2b8\ub108\uc5d0\uac8c \ub77c\uc774\uc120\uc2a4\ud568\uc73c\ub85c\uc368 2030\ub144\uae4c\uc9c0 15.23%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc774\ub4e4 \ub300\ud559 \uae30\ubc18 \uc13c\ud130\ub294 \uc0c1\uc5c5\uc801 \uc9c4\uc785 \uae30\uc5c5\uc758 \uac1c\ubc1c \uc8fc\uae30\ub97c \ub2e8\ucd95\ud558\uae30 \uc704\ud574 \uc2e0\uaddc \uad6c\uc870\uccb4\uc758 \uc704\ud5d8\uc744 \uc904\uc774\ub294 \ucd08\uae30 \ub2e8\uacc4 \uc784\uc0c1 \uc2dc\ud5d8\uc744 \uc218\ud589\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc9c0\uc5ed \ubd84\uc11d<\/p>\n<p>\ubd81\ubbf8\ub294 2024\ub144 \uc2dc\uc7a5 \uc810\uc720\uc728\uc758 38.35%\ub97c \ucc28\uc9c0\ud558\uba70 \ubca4\ucc98 \uce90\ud53c\ud0c8, \ud559\uacc4 \ubc0f \uaddc\uc81c \uc18d\ub3c4\ub97c \uc5f0\uacb0\ud558\ub294 \ud1b5\ud569 \uc0dd\ud0dc\uacc4\ub97c \ubc18\uc601\ud569\ub2c8\ub2e4. \ubbf8\uad6d\uc740 \uc790\ubcf8 \uc704\ud5d8\uc744 \uc904\uc774\ub294 \uc6b0\uc120 \uc2ec\uc0ac \ubc14\uc6b0\ucc98 \ubc0f \ud76c\uadc0\uc758\uc57d\ud488 \uc778\uc13c\ud2f0\ube0c\ub97c \uc81c\uacf5\ud558\uba70, \uad6d\ub9bd\uc554\uc5f0\uad6c\uc18c(National Cancer Institute) \ub124\ud2b8\uc6cc\ud06c\ub294 \ucca8\ub2e8 \uba74\uc5ed \uce58\ub8cc\uc81c\uc5d0 \uacbd\ud5d8\uc774 \uc788\ub294 \uc784\uc0c1 \uc2dc\ud5d8 \uae30\uad00\uc744 \uacf5\uae09\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591\uc740 \uaddc\uc81c \uae30\uad00\uc774 \ud45c\uc900\uc744 \uc870\ud654\uc2dc\ud0a4\uace0 \uc2e0\uc18d \uc2b9\uc778 \uacbd\ub85c\ub97c \ud655\ub300\ud568\uc5d0 \ub530\ub77c 2030\ub144\uae4c\uc9c0 14.26%\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \ud638\uc8fc \uc758\uc57d\ud488 \uad00\ub9ac\uad6d(TGA)\uc740 \ucd5c\ucd08\uc758 PD-1 \uba74\uc5ed\uad00\ubb38\uc5b5\uc81c\uc81c \uc5f0\uacc4 \uba74\uc5ed\uc0ac\uc774\ud1a0\uce74\uc778\uc744 \uc2b9\uc778\ud558\uc5ec \uad6d\uc81c \ub370\uc774\ud130 \ud328\ud0a4\uc9c0\ub97c \ud65c\uc6a9\ud558\ub824\ub294 \uc9c0\uc5ed\uc801 \uc758\uc9c0\ub97c \ubcf4\uc5ec\uc8fc\uc5c8\uc2b5\ub2c8\ub2e4. \uc77c\ubcf8 \uc758\uc57d\ud488\uc758\ub8cc\uae30\uae30\uc885\ud569\uae30\uad6c(PMDA)\ub294 \uc0ac\ud0a4\uac00\ucf00(Sakigake) \uc2e0\uc18d \uc2ec\uc0ac \uc9c0\uc815\uc744 \ud1b5\ud574 \uc2ec\uc0ac \uc8fc\uae30\ub97c 6\uac1c\uc6d4 \ub2e8\ucd95\ud558\uc5ec \uc2a4\ud3f0\uc11c\ub4e4\uc774 \ud604\uc9c0\uc5d0\uc11c \uac00\uad50 \uc5f0\uad6c\ub97c \uc218\ud589\ud558\ub3c4\ub85d \uc720\ub3c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc720\ub7fd\uc740 \uc720\ub7fd\uc758\uc57d\ud488\uccad(EMA)\uc758 \uc911\uc559 \uc9d1\uc911\uc2dd \uc2b9\uc778 \uc808\ucc28\uc640 \uac15\ub825\ud55c \ud559\uacc4-\uc0b0\uc5c5 \ucee8\uc18c\uc2dc\uc5c4\uc5d0 \ud798\uc785\uc5b4 \uafb8\uc900\ud55c \uc131\uc7a5\uc744 \uc720\uc9c0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub3c5\uc77c\uc758 \ubc14\uc774\uc624\uc5d4\ud14d(BioNTech) \uc8fc\ub3c4 \uc0dd\ud0dc\uacc4\ub294 \ubca1\ud130 \uc778\ucf54\ub529 \uc0ac\uc774\ud1a0\uce74\uc778\uc5d0 \uc801\uc6a9 \uac00\ub2a5\ud55c mRNA \ub178\ud558\uc6b0\ub97c \uc81c\uacf5\ud558\uba70, \uc601\uad6d\uc758 MHRA\ub294 \ucca8\ub2e8 \uce58\ub8cc\uc81c\uc5d0 \uc720\ub9ac\ud55c \ub864\ub9c1 \ub9ac\ubdf0(rolling reviews)\ub97c \uc2dc\ubc94 \uc6b4\uc601\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd<\/p>\n<p>\uba74\uc5ed\uc0ac\uc774\ud1a0\uce74\uc778 \uc2dc\uc7a5\uc740 \uc911\uac04 \uc815\ub3c4\uc758 \uc9d1\uc911\ub3c4\ub97c \ubcf4\uc774\uba70, \uc0c1\uc704 5\uac1c \uac1c\ubc1c\uc0ac\uac00 \uc804\uccb4 \uc218\uc775\uc758 \uc57d 45%\ub97c \ucc28\uc9c0\ud558\uace0 \uc788\uc5b4 \ud6c4\ubc1c \uc8fc\uc790\ub4e4\uc5d0\uac8c \uc0c1\ub2f9\ud55c \uc131\uc7a5 \uc5ec\uc9c0\uac00 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ubba4\ub2c8\ud2f0\ubc14\uc774\uc624(ImmunityBio)\ub294 \uc2dc\uc7a5 \uc120\uc810 \uc9c0\uc704\uc640 \uac15\ub825\ud55c \uc81c\uc870 \uaddc\ubaa8\ub97c \ud65c\uc6a9\ud558\uc5ec \uc810\uc720\uc728\uc744 \ubc29\uc5b4\ud558\uace0 \uc788\uc73c\uba70, \ub125\ud0c0 \ud14c\ub77c\ud4e8\ud2f1\uc2a4(Nektar Therapeutics)\ub294 \uc885\uc591 \uc870\uac74\ubd80 \ud65c\uc131\ud654 \uae30\uc220\ub85c \uc804\ud658\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc2e4\ub9ac\uc624 \ud14c\ub77c\ud4e8\ud2f1\uc2a4(Xilio Therapeutics)\uc758 \ud504\ub85c\ud14c\uc544\uc81c-\ud65c\uc131\ud654 \uc0ac\uc774\ud1a0\uce74\uc778\uacfc GT \ubc14\uc774\uc624\ud30c\ub9c8(GT Biopharma)\uc758 TriKE \ud50c\ub7ab\ud3fc\uc740 \uc885\uc591 \ubbf8\uc138\ud658\uacbd \uc7a5\ubcbd\uc744 \ud45c\uc801\uc73c\ub85c \ud558\ub294 \ud2b9\uc218 \uc5d4\uc9c0\ub2c8\uc5b4\ub9c1\uc744 \uc120\ubcf4\uc785\ub2c8\ub2e4. \ube0c\ub9ac\uc2a4\ud1a8 \ub9c8\uc774\uc5b4\uc2a4 \uc2a4\ud045(Bristol Myers Squibb), \uc560\ube0c\ube44(AbbVie), \uc0ac\ub178\ud53c(Sanofi)\uc640 \uac19\uc740 \ub300\ud615 \uc81c\uc57d\uc0ac\ub4e4\uc740 \ub77c\uc774\uc120\uc2f1 \uacc4\uc57d\uc744 \ud1b5\ud574 \ud30c\uc774\ud504\ub77c\uc778\uc744 \ub2e4\uac01\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc804\ub7b5\uc801 \ucd08\uc810\uc740 \uc81c\uc5b4 \uac00\ub2a5\uc131, \uad6d\uc18c \uc804\ub2ec, \uba74\uc5ed\uad00\ubb38\uc5b5\uc81c\uc81c\uc640\uc758 \ubcd1\uc6a9 \uc694\ubc95\uc744 \ud1b5\ud55c \ucc28\ubcc4\ud654\uc5d0 \ub9de\ucdb0\uc838 \uc788\uc2b5\ub2c8\ub2e4. \uae30\uc5c5\ub4e4\uc740 \uc735\ud569 \ud615\uc2dd, \ub9c8\uc2a4\ud0b9 \ub9c1\ucee4 \ubc0f \ubca1\ud130 \ud398\uc774\ub85c\ub4dc \uc544\ud0a4\ud14d\ucc98\uc5d0 \ub300\ud55c \uc911\ubcf5 \uccad\uad6c\ub97c \ud1b5\ud574 \uc9c0\uc801 \uc7ac\uc0b0\uad8c(IP)\uc758 \ud3ed\uc744 \ub113\ud788\ub294 \ub370 \uc8fc\ub825\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc18c\uaddc\ubaa8 \ud601\uc2e0 \uae30\uc5c5\uacfc \uc219\ub828\ub41c \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c \uacf5\uc7a5 \uac04\uc758 \uc81c\uc870 \ub3d9\ub9f9\uc740 \uc2a4\ucf00\uc77c\uc5c5 \uc704\ud5d8\uc744 \uc644\ud654\ud569\ub2c8\ub2e4. \ud559\uc220 \uc2a4\ud540\uc624\ud504 \uae30\uc5c5\ub4e4\uc740 \ud30c\uad34\uc801\uc778 \uc544\uc774\ub514\uc5b4\ub97c \uc721\uc131\ud558\uba70, \ubca4\ucc98 \uce90\ud53c\ud0c8(VC) \uc2e0\ub514\ucf00\uc774\ud2b8\ub294 \uc885\uc591\ud559, \uc790\uac00\uba74\uc5ed \uc9c8\ud658 \ubc0f \uac10\uc5fc\uc131 \uc9c8\ud658\uc744 \ub2e8\uc77c \ud50c\ub7ab\ud3fc\uc73c\ub85c \ud574\uacb0\ud560 \uc218 \uc788\ub294 \ud50c\ub7ab\ud3fc \ub2e4\uc6a9\ub3c4\uc131\uc744 \uc6b0\uc120\uc2dc\ud569\ub2c8\ub2e4.<\/p>\n<p>\ucd5c\uadfc \uc0b0\uc5c5 \ub3d9\ud5a5<\/p>\n<p>*   2025\ub144 7\uc6d4: \uc560\ube0c\ube44(AbbVie)\ub294 \uc7ac\ubc1c\uc131\/\ubd88\uc751\uc131 \ub2e4\ubc1c\uc131 \uace8\uc218\uc885\uc5d0\uc11c 79%\uc758 \uc804\uccb4 \ubc18\uc751\ub960\uc744 \ubcf4\uc778 CD38\u00d7BCMA\u00d7CD3 \uc0bc\uc911\ud2b9\uc774\uc131 \ud56d\uccb4\uc778 ISB 2001\uc5d0 \ub300\ud574 \uc774\ud06c\ub178\uc2a4 \uae00\ub80c\ub9c8\ud06c \uc774\ub178\ubca0\uc774\uc158(Ichnos Glenmark Innovation)\uacfc \ub3c5\uc810\uc801\uc778 \uc804 \uc138\uacc4 \ub77c\uc774\uc120\uc2a4 \uacc4\uc57d\uc744 \uccb4\uacb0\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 6\uc6d4: \uc774\ubba4\ub2c8\ud2f0\ubc14\uc774\uc624(ImmunityBio)\ub294 \ud654\ud559\ubc29\uc0ac\uc120 \uc694\ubc95\uc744 \ubc1b\ub294 \ud658\uc790\uc758 \ub9bc\ud504\uad6c \uac10\uc18c\uc99d\uc744 \uc5ed\uc804\uc2dc\ud0a4\uae30 \uc704\ud55c \uc548\ud06c\ud2f0\ubc14(ANKTIVA)\uc640 CAR-NK \ubcd1\uc6a9 \uc694\ubc95\uc5d0 \ub300\ud574 FDA RMAT(\uc7ac\uc0dd\uc758\ud559 \ucca8\ub2e8\uce58\ub8cc\uc81c) \uc9c0\uc815\uc744 \ubc1b\uc558\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 4\uc6d4: \uc774\ubba4\ub2c8\ud2f0\ubc14\uc774\uc624(ImmunityBio)\ub294 \ube44\uadfc\uce68\uc724\uc131 \ubc29\uad11\uc554 \ud658\uc790\ub97c \ub300\uc0c1\uc73c\ub85c \ud55c \uc548\ud06c\ud2f0\ubc14(ANKTIVA) + BCG \ubcd1\uc6a9 \uc694\ubc95\uc5d0\uc11c 36\uac1c\uc6d4 \uc2dc\uc810\uc5d0 71%\uc758 \uc644\uc804 \ubc18\uc751\ub960\uacfc 84%\uc758 \ubc29\uad11 \uc808\uc81c\uc220 \ud68c\ud53c\uc728\uc744 \ubcf4\uace0\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 2\uc6d4: \uc778\ubba4\ub124 \ubc14\uc774\uc624(INmune Bio)\ub294 \uae0d\uc815\uc801\uc778 MissionEB \ub370\uc774\ud130\uc5d0 \ub530\ub77c \uc18c\uc544 \uc5f4\uc131 \uc774\uc601\uc591\uc131 \uc218\ud3ec\uc131 \ud45c\ud53c\ubc15\ub9ac\uc99d(Recessive Dystrophic Epidermolysis Bullosa) \uce58\ub8cc\ub97c \uc704\ud55c \uc911\uac04\uc5fd \uc904\uae30\uc138\ud3ec \uce58\ub8cc\uc81c\uc778 CORDStrom\uc5d0 \ub300\ud55c \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c \ud5c8\uac00 \uc2e0\uccad(BLA) \uacc4\ud68d\uc744 \ubc1c\ud45c\ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc774 \ubcf4\uace0\uc11c\ub294 \uae00\ub85c\ubc8c \uba74\uc5ed\uc0ac\uc774\ud1a0\uce74\uc778(Immunocytokines) \uc2dc\uc7a5\uc5d0 \ub300\ud55c \uc2ec\uce35 \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \uba74\uc5ed\uc0ac\uc774\ud1a0\uce74\uc778\uc740 \uba74\uc5ed \uc790\uadf9 \uc0ac\uc774\ud1a0\uce74\uc778\uacfc \ud45c\uc801\ud654 \ubd80\ubd84(\uc885\uc885 \ud56d\uccb4 \ub2e8\ud3b8)\uc744 \uc5f0\uacb0\ud558\ub294 \uc735\ud569 \ub2e8\ubc31\uc9c8\ub85c, \uc9c8\ubcd1 \uc870\uc9c1\uc5d0 \uc9c1\uc811 \uc0ac\uc774\ud1a0\uce74\uc778\uc744 \uc804\ub2ec\ud558\uc5ec \uad6d\uc18c \uba74\uc5ed \ud65c\ub3d9\uc744 \uc99d\uc9c4\uc2dc\ud0a4\uba74\uc11c \uc804\uc2e0 \ub3c5\uc131\uc744 \uc81c\ud55c\ud558\ub294 \uac83\uc744 \ubaa9\ud45c\ub85c \ud569\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc804\ub9dd:<br \/>\n\uba74\uc5ed\uc0ac\uc774\ud1a0\uce74\uc778 \uc2dc\uc7a5\uc740 2025\ub144\uc5d0 10\uc5b5 3\ucc9c\ub9cc \ub2ec\ub7ec \uaddc\ubaa8\ub97c \uae30\ub85d\ud588\uc73c\uba70, 2030\ub144\uc5d0\ub294 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 12.24%\ub85c \uc131\uc7a5\ud558\uc5ec 18\uc5b5 4\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0 \uc774\ub97c \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \ub3d9\uc778:<br \/>\n\uc2dc\uc7a5\uc758 \uc131\uc7a5\uc744 \uacac\uc778\ud558\ub294 \uc8fc\uc694 \uc694\uc778\uc73c\ub85c\ub294 IL-2 \uae30\ubc18 \uc735\ud569 \uce58\ub8cc\uc81c\uc758 \uc784\uc0c1\uc801 \uc131\uacf5\uacfc \uc774\uc5d0 \ub530\ub978 \ud22c\uc790 \uc720\uce58 \uc99d\uac00\uac00 \uc788\uc2b5\ub2c8\ub2e4. \ub610\ud55c, \uba74\uc5ed\uc0ac\uc774\ud1a0\uce74\uc778\uacfc \uccb4\ud06c\ud3ec\uc778\ud2b8 \uc5b5\uc81c\uc81c \ubcd1\uc6a9 \uc694\ubc95\uc758 \ucc44\ud0dd\uc774 \ud655\uc0b0\ub418\uace0 \uc788\uc73c\uba70, \uc81c\uc870 \ud50c\ub7ab\ud3fc\uc758 \ubc1c\uc804\uc73c\ub85c \uc0dd\uc0b0 \ube44\uc6a9(COGS)\uc774 \uc808\uac10\ub418\uace0 \ubc30\uce58 \uc2e4\ud328\uc728\uc774 \ub0ae\uc544\uc9c0\ub294 \uc810\ub3c4 \uae0d\uc815\uc801\uc778 \uc601\ud5a5\uc744 \ubbf8\uce58\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc790\uac00\uba74\uc5ed \uc9c8\ud658(\uc608: F8-IL10)\uc73c\ub85c\uc758 \ud30c\uc774\ud504\ub77c\uc778 \ud655\uc7a5, \ud76c\uadc0 \uc885\uc591\uc5d0 \ub300\ud55c \ud76c\uadc0\uc758\uc57d\ud488 \uc778\uc13c\ud2f0\ube0c, \uadf8\ub9ac\uace0 \uc628\ub514\ub9e8\ub4dc(on-demand) \uc18c\ubd84\uc790 \uc2a4\uc704\uce58\ud615 \uba74\uc5ed\uc0ac\uc774\ud1a0\uce74\uc778 \uac1c\ubc1c \ub610\ud55c \uc2dc\uc7a5 \uc131\uc7a5\uc744 \ucd09\uc9c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc81c\uc57d \uc694\uc778:<br \/>\n\ubc18\uba74, \uc0ac\uc774\ud1a0\uce74\uc778 \ubc29\ucd9c \uc99d\ud6c4\uad70(CRS) \ubc0f \uad00\ub828 \uc548\uc804\uc131 \ubb38\uc81c, \ub192\uc740 GMP \uc2a4\ucf00\uc77c\uc5c5 \ubc0f \ud488\uc9c8 \ubcf4\uc99d\/\ud488\uc9c8 \uad00\ub9ac(QA\/QC) \ube44\uc6a9\uc740 \uc2dc\uc7a5 \uc131\uc7a5\uc758 \uc8fc\uc694 \uc81c\uc57d \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud569\ub2c8\ub2e4. \ub610\ud55c, \ubc14\uc774\uc624\ub9c8\ucee4 \uae30\ubc18\uc758 \ud658\uc790 \uacc4\uce35\ud654\uac00 \uc544\uc9c1 \ubbf8\ud761\ud558\uba70, \uc774\uc911\ud2b9\uc774\uc131 \ud56d\uccb4 \ubc0f \uc138\ud3ec \uce58\ub8cc\uc81c\uc640 \uac19\uc740 \uacbd\uc7c1 \ubaa8\ub2ec\ub9ac\ud2f0\uc758 \ubd80\uc0c1\ub3c4 \uc2dc\uc7a5\uc5d0 \uc555\ub825\uc73c\ub85c \uc791\uc6a9\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \uc138\ubd84\ud654 \ubd84\uc11d:<br \/>\n*   \uc0ac\uc774\ud1a0\uce74\uc778 \uc720\ud615\ubcc4: IL-2 \uae30\ubc18 \uba74\uc5ed\uc0ac\uc774\ud1a0\uce74\uc778\uc774 2024\ub144 \uc2dc\uc7a5 \uc810\uc720\uc728 39.24%\ub85c \uac00\uc7a5 \ud070 \ube44\uc911\uc744 \ucc28\uc9c0\ud558\uba70 \uc2dc\uc7a5\uc744 \uc8fc\ub3c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub294 \ubc29\uad11\uc554 \uce58\ub8cc\uc81c ANKTIVA\uc758 \ucd5c\ucd08 \uc2b9\uc778\uc73c\ub85c \uadf8 \uc720\ud6a8\uc131\uc774 \uc785\uc99d\ub418\uc5c8\uc2b5\ub2c8\ub2e4. \uc774 \uc678\uc5d0\ub3c4 IL-12, IL-15, IFN-\u03b1, TNF-\u03b1 \uae30\ubc18 \uba74\uc5ed\uc0ac\uc774\ud1a0\uce74\uc778 \ubc0f \uae30\ud0c0 \uc720\ud615(IL-21, GM-CSF, \ubcf5\ud569\uc81c)\uc774 \ubd84\uc11d\ub418\uc5c8\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uce58\ub8cc \uc601\uc5ed\ubcc4: \uc885\uc591\ud559 \ubd84\uc57c\uac00 \uac00\uc7a5 \ud070 \ube44\uc911\uc744 \ucc28\uc9c0\ud558\uba70, \uc790\uac00\uba74\uc5ed \ubc0f \uc5fc\uc99d\uc131 \uc9c8\ud658, \uac10\uc5fc\uc131 \uc9c8\ud658, \uae30\ud0c0 \uc9c8\ud658(\uc12c\uc720\uc99d, \uc548\uacfc \uc9c8\ud658) \ub4f1\uc774 \ud3ec\ud568\ub429\ub2c8\ub2e4.<br \/>\n*   \uc804\ub2ec \ubc29\uc2dd\ubcc4: \uc804\uc2e0 \uc815\ub9e5 \uc8fc\uc0ac(Systemic IV), \uc885\uc591 \ub0b4 \uc8fc\uc0ac(Intratumoral Injection), \uc720\uc804\uc790\/\ubca1\ud130 \uc778\ucf54\ub529(mRNA, \ubc14\uc774\ub7ec\uc2a4 \ub4f1), \uc6a9\ud574\uc131 \ubc14\uc774\ub7ec\uc2a4 \uc804\ub2ec(Oncolytic-virus Delivered) \ubc29\uc2dd\uc774 \uac80\ud1a0\ub418\uc5c8\uc2b5\ub2c8\ub2e4.<br \/>\n*   \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4: \uc81c\uc57d \ubc0f \ubc14\uc774\uc624 \uae30\uc5c5, \ud559\uc220 \ubc0f \uc5f0\uad6c \uae30\uad00, \uc704\ud0c1 \uc0dd\uc0b0 \uae30\uad00(CMO), \ubcd1\uc6d0\/\uc804\ubb38 \ud074\ub9ac\ub2c9 \ub4f1\uc774 \uc8fc\uc694 \ucd5c\uc885 \uc0ac\uc6a9\uc790\uc785\ub2c8\ub2e4.<br \/>\n*   \uc9c0\uc5ed\ubcc4: \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 2030\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 14.26%\uc758 \uac00\uc7a5 \ube60\ub978 \uc131\uc7a5\ub960\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc774\ub294 \uc2e0\uc18d\ud55c \uaddc\uc81c \uac80\ud1a0, \ud638\uc8fc, \uc77c\ubcf8, \uc911\uad6d, \uc778\ub3c4 \ub4f1\uc5d0\uc11c\uc758 \uc784\uc0c1 \uc2dc\ud5d8 \uc5ed\ub7c9 \ud655\ub300, \uadf8\ub9ac\uace0 \uc804\ub7b5\uc801 \uc81c\uc870 \ud30c\ud2b8\ub108\uc2ed \uc99d\uac00\uc5d0 \uae30\uc778\ud569\ub2c8\ub2e4. \ubd81\ubbf8, \uc720\ub7fd, \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8 \uc9c0\uc5ed\ub3c4 \uc0c1\uc138\ud788 \ubd84\uc11d\ub418\uc5c8\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd:<br \/>\n\ubcf4\uace0\uc11c\ub294 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4, \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d\uc744 \ud3ec\ud568\ud55c \uacbd\uc7c1 \ud658\uacbd\uc744 \ub2e4\ub8e8\uba70, Philogen S.p.A., Nektar Therapeutics, ImmunityBio Inc., F. Hoffmann-La Roche AG, Novartis AG, Bristol Myers Squibb Co., Sanofi S.A. \ub4f1 \uc8fc\uc694 19\uac1c \uae30\uc5c5\uc758 \ud504\ub85c\ud544\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd:<br \/>\n\uba74\uc5ed\uc0ac\uc774\ud1a0\uce74\uc778 \uc2dc\uc7a5\uc740 \ubbf8\ucda9\uc871 \uc218\uc694\uac00 \ub192\uc740 \ubd84\uc57c\uc5d0\uc11c \uc0c1\ub2f9\ud55c \uc131\uc7a5 \uae30\ud68c\ub97c \uac00\uc9c0\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uac1c\ubc1c\uc790\ub4e4\uc740 \uc0ac\uc774\ud1a0\uce74\uc778 \ubc29\ucd9c \uc99d\ud6c4\uad70\uacfc \uac19\uc740 \uc548\uc804\uc131 \uc704\ud5d8\uc744 \uc644\ud654\ud558\uae30 \uc704\ud574 \uc6a9\ub7c9 \uc801\uc815, \ubc14\uc774\uc624\ub9c8\ucee4 \ubaa8\ub2c8\ud130\ub9c1, \uc628\ub514\ub9e8\ub4dc \ud65c\uc131 \uc124\uacc4 \ub4f1 \ub2e4\uc591\ud55c \uc804\ub7b5\uc744 \ud65c\uc6a9\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c \ub178\ub825\uc740 \uba74\uc5ed\uc0ac\uc774\ud1a0\uce74\uc778\uc774 \uad6d\uc18c \uba74\uc5ed \ubc18\uc751\uc744 \uac15\ud654\ud558\uace0 \uc804\uc2e0 \ub3c5\uc131\uc744 \uc904\uc774\ub294 \ud601\uc2e0\uc801\uc778 \uce58\ub8cc\uc81c\ub85c \uc790\ub9ac\ub9e4\uae40\ud558\ub294 \ub370 \uae30\uc5ec\ud560 \uac83\uc785\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-49625","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/49625"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=49625"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/49625\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=49625"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=49625"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=49625"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}